BioCentury
ARTICLE | Company News

Abeille, ProStrakan deal

March 30, 2009 7:00 AM UTC

ProStrakan received exclusive, worldwide rights excluding certain Asian territories to develop, commercialize and sub-license Abeille's AB-1001. The transdermal granisetron patch has completed Phase...